NCT00109135 A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers (0364-007) Status COMPLETED Phase PHASE2
NCT00109122 Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007) Status COMPLETED Phase PHASE2
NCT00109109 A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Multiple Myeloma (0683-004) Status TERMINATED Phase PHASE1
NCT00108017 Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00106808 Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00106704 Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035) Status COMPLETED Phase PHASE3
NCT00106145 A Notch Signalling Pathway Inhibitor for Patients With Advanced Breast Cancer (0752-014) Status COMPLETED Phase PHASE1
NCT00105534 Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003) Status COMPLETED Phase PHASE3
NCT00105469 Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004) Status COMPLETED Phase PHASE3
NCT00105157 Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED) Status COMPLETED Phase PHASE2
NCT00104364 A Study of MK0731 in Patients With Advanced Solid Tumors (0731-002)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00104052 Study of PEG-Intron Plus REBETOL in Pediatric Subjects With Chronic Hepatitis C (Study P02538 Part 1) Status COMPLETED Phase PHASE3
NCT00103857 MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036) Status COMPLETED Phase PHASE3
NCT00103714 Study of Denufosol Tetrasodium in Patients With Cystic Fibrosis Lung Disease Status COMPLETED Phase PHASE2
NCT00100152 A Notch Signalling Pathway Inhibitor for Patients With T-cell Acute Lymphoblastic Leukemia/Lymphoma (ALL)(0752-013) Status TERMINATED Phase PHASE1
NCT00100048 A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED) Status COMPLETED Phase PHASE2
NCT00099450 Study of the Tolerability, Pharmacokinetics, and Pharmacodynamics of INS50589 Intravenous Infusion in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00099346 MK0457 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Colorectal Cancer and Other Advanced Solid Tumors (0457-001) Status TERMINATED Phase PHASE1
NCT00097929 An Investigational Drug Study With Suberoylanilide Hydroxamic Acid in Relapsed Diffuse Large B-cell Lymphoma (0683-013) Status COMPLETED Phase PHASE2